Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Freya Meds vs Rivas Medical Weight Loss

Freya Meds
Graded #364

Higher grade

vs+3
Rivas Medical Weight Loss
Graded #438

Lower grade

The verdict

Freya Meds takes it — 58.6/100 to 55.6/100.

Freya Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Freya Meds is a GLP-1 specialist offering compounded semaglutide ($250–$297/mo) and compounded tirzepatide ($332–$390/mo).

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueRivas Medical Weight Loss +2
43
45
Dose & formulationFreya Meds +24
64
40
Clinical oversightRivas Medical Weight Loss +10
71
81
Labs & monitoringFreya Meds +7
60
53
FulfillmentRivas Medical Weight Loss +3
62
65
Contract termsEven
55
55
Freya Meds · left barRivas Medical Weight Loss · right bar

The numbers

MetricFreya MedsRivas Medical Weight Loss
WeighScore58.6/10055.6/100
GradeCC
Scorecard rank#364#438
Semaglutide$297/mo (compounded)Not disclosed
Tirzepatide$390/mo (compounded)Not disclosed
CoverageCoverage not published3 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Freya Meds

Graded #364 · C

Strengths

  • GLP-1 specialist — not a multi-category telehealth
  • Price includes unlimited doctor consultations, monthly group calls, and a dietitian consultation
  • Both semaglutide and tirzepatide available
  • Multi-month discount on quarterly billing
  • Claims 450,000+ enrolled

Where it loses points

  • No visible LegitScript or PCAB accreditation
  • Above-average pricing ($250–$390/mo)
  • Compounded only — no brand-name options
  • Now serves 49 U.S. states (one state excluded; specific exclusion not named)

Strengths

  • Physician-founded (Paul Rivas MD) with 15 clinics plus telehealth
  • Flat price for any dose; weekly provider visits included in every payment
  • Offers both compounded semaglutide and tirzepatide

Where it loses points

  • Expensive: about $498/mo for semaglutide and $715/mo for tirzepatide (billed weekly)
  • Only available in Maryland, Virginia, and Florida
  • Weekly-visit concierge model requires more frequent engagement than mail-order

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard